These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 1864816

  • 21. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease.
    Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW.
    J Clin Invest; 1980 Jan; 65(1):154-60. PubMed ID: 7350195
    [Abstract] [Full Text] [Related]

  • 22. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P, Alyaarubi S, Abish S, Gale M, Albuquerque P, Jabado N.
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [Abstract] [Full Text] [Related]

  • 23. Cytokine profile of sickle cell disease in Oman.
    Pathare A, Al Kindi S, Alnaqdy AA, Daar S, Knox-Macaulay H, Dennison D.
    Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
    [Abstract] [Full Text] [Related]

  • 24. Role of oxidative stress in the pathogenesis of sickle cell disease.
    Chirico EN, Pialoux V.
    IUBMB Life; 2012 Jan; 64(1):72-80. PubMed ID: 22131167
    [Abstract] [Full Text] [Related]

  • 25. Modulation of erythroid adhesion receptor expression by hydroxyurea in children with sickle cell disease.
    Odièvre MH, Bony V, Benkerrou M, Lapouméroulie C, Alberti C, Ducrocq R, Jacqz-Aigrain E, Elion J, Cartron JP.
    Haematologica; 2008 Apr; 93(4):502-10. PubMed ID: 18322255
    [Abstract] [Full Text] [Related]

  • 26. Established and experimental treatments for sickle cell disease.
    De Franceschi L, Corrocher R.
    Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
    [Abstract] [Full Text] [Related]

  • 27. Pathophysiologically based drug treatment of sickle cell disease.
    Steinberg MH.
    Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854
    [Abstract] [Full Text] [Related]

  • 28. Sickle cell vaso-occlusion: multistep and multicellular paradigm.
    Frenette PS.
    Curr Opin Hematol; 2002 Mar; 9(2):101-6. PubMed ID: 11844991
    [Abstract] [Full Text] [Related]

  • 29. Sickle red cell adhesion: many issues and some answers.
    Kaul DK.
    Transfus Clin Biol; 2008 Mar; 15(1-2):51-5. PubMed ID: 18495516
    [Abstract] [Full Text] [Related]

  • 30. Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report.
    Ahmed S, Siddiqui AK, Iqbal U, Sison CP, Shahid RK, Sheth M, Patel DV, Russo LA.
    Eur J Haematol; 2004 Mar; 72(3):213-6. PubMed ID: 14962240
    [Abstract] [Full Text] [Related]

  • 31. Blood rheology abnormalities and vascular cell adhesion mechanisms in sickle cell trait carriers during exercise.
    Connes P, Hue O, Tripette J, Hardy-Dessources MD.
    Clin Hemorheol Microcirc; 2008 Mar; 39(1-4):179-84. PubMed ID: 18503123
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pathophysiologic considerations for the interactions between obstructive sleep apnea and sickle hemoglobinopathies.
    Okoli K, Irani F, Horvath W.
    Med Hypotheses; 2009 May; 72(5):578-80. PubMed ID: 19138828
    [Abstract] [Full Text] [Related]

  • 34. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
    Noguchi CT, Rodgers GP, Schechter AN.
    Prog Clin Biol Res; 1987 May; 240():381-91. PubMed ID: 3615501
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Falciform anemia and Plasmodium falciparum malaria: a threat to flap survival?].
    Mariéthoz S, Pittet B, Loutan L, Humbert J, Montandon D.
    Ann Chir Plast Esthet; 1999 Feb; 44(1):81-8. PubMed ID: 10188298
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion.
    Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM.
    Blood; 1993 Apr 15; 81(8):2137-43. PubMed ID: 8471771
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.